Don't miss this upcoming event! Join us on March 17 to learn more about lessons learned from North Carolina's Healthy Opportunities Pilots program, and how its strategic and operational elements make the program a model for bipartisan health reform. Speakers will highlight examples of the Pilots’ impacts on health, well-being, and local economies in communities across the state, as well as areas where evidence is still emerging. Learn more and register here: https://duke.is/c/pdyf
Duke-Margolis Institute for Health Policy
公共政策
Washington,District of Columbia 7,089 位关注者
Improving health and the value of health care through practical, innovative, and evidence-based policy solutions.
关于我们
The mission of Duke University's Robert J. Margolis, MD, Institute for Health Policy is to improve health, health equity, and the value of health care through practical, innovative, and evidence-based policy solutions. Duke-Margolis catalyzes Duke University's leading capabilities including interdisciplinary academic research and capacity for education and engagement, to inform policy making and implementation for better health and health care.
- 网站
-
https://healthpolicy.duke.edu/
Duke-Margolis Institute for Health Policy的外部链接
- 所属行业
- 公共政策
- 规模
- 51-200 人
- 总部
- Washington,District of Columbia
- 类型
- 教育机构
- 创立
- 2016
地点
Duke-Margolis Institute for Health Policy员工
-
Amanda McBroom, Ph.D.
-
Gerrit Hamre
Research Director at Duke-Margolis Center for Health Policy
-
Tiffany Chan
Senior Program Coordinator |Accomplished higher education professional | Effective collaborator | Team-oriented
-
David Ridley
Faculty Director, Health Sector Management, Fuqua School of Business
动态
-
Duke-Margolis Institute for Health Policy转发了
Sharing our latest commentary published in Learning Health Systems, entitled "Landscape of informed consent practices and challenges in point-of-care clinical trials." Here, we describe, overall and through the use of real-world examples, how ethical standards for point-of-care trials are vital to ensuring a modern clinical trial enterprise that is patient-centered and equips patients to make fully informed decisions about their health care. Importantly, we present technical and practical considerations for obtaining informed consent in point-of-care research intended to address important pharmacoepidemiologic questions regarding treatment effectiveness. Read it here ---> https://lnkd.in/eTdWpJEw Caleigh Propes Trevan Locke, PhD Duke-Margolis Institute for Health Policy #ethics #innovation #learninghealthsystem #pointofcare #clinicaltrials
-
We are #hiring Policy Research Assistants in both our Biomedical Innovation and Health Care Transformation portfolios! If you are interested in improving health care for all and have strong policy research and writing skills, we invite you to apply here: https://lnkd.in/eQWBkEG #careers #healthpolicyjobs #researchjobs
-
In just a few weeks, we're hosting a webinar to present our updated policy framework for reducing viral transmission. Speakers will discuss ways to improve evidence generation on indirect benefits and build on existing federal capacity to incorporate indirect benefits in approval, reimbursement, and use pathways. We invite you to join us for this critical conversation! Read the draft agenda and register here:https://duke.is/j/ey9e
-
-
Tomorrow, Institute Director Mark McClellan joins the National Academy of Medicine for their event, "Vital Directions for Health & Health Care: Priorities for 2025." This event follows up on a series of papers recently published in Health Affairs, including one that Mark co-authored, which provide policy recommendations for several key areas of health care. Mark and his fellow speakers will discuss the key actions outlined in this Vital Directions series during this virtual event—there's still time to register! Learn more here: https://duke.is/z/gss3
-
Health Care Value Week is here! This year, #HCValueWeek is set to offer diverse chances for stakeholders, health care leaders, and government officials to participate in critical discussions concerning the progress of value-based care (VBC) approaches. VBC prioritizes patients’ health outcomes over the quantity of visits and treats people as whole individuals, not just a set of symptoms. To learn more about Health Care Value Week and access resources, please visit www.hcvalueweek.org.
-
-
Learn more about the Centers for Medicare & Medicaid Services' Guiding an Improved Dementia Experience (GUIDE) model of care in this new podcast episode from Michigan Medicine. Core Faculty member Brystana Kaufman (she/her) discusses the development and implementation of GUIDE, and shares insights on what services an organization might need to offer to participate in the model's implementation. Listen to the podcast or read the transcript here: https://duke.is/5/7vb2
-
We've announced a new webinar! Join us on March 19 as we discuss the future of accountable care, five years after the Centers for Medicare & Medicaid Services set their ambitious 2030 goals. As growth in accountable care programs in Traditional Medicare continues and the majority of Medicare beneficiaries are now in Medicare Advantage plans, questions about the future and sustainability of accountable care models are emerging amidst the backdrop of priorities being set by the new presidential administration. Learn more and register here: https://duke.is/g/tp77
-
-
Hear from Assistant Research Director Trevan Locke, PhD, in Clinical Research as a Care Option's latest podcast! Speakers discussed the challenges and opportunities surrounding coverage for clinical trials. Learn more below:
This podcast features a discussion on the financial barriers to getting coverage for clinical trials, coverage by sponsors vs standard of care and new developments for the audience to be aware of. Speakers include: ? Trevan Locke, Duke-Margolis Institute for Health Policy ? Donna O'Brien, Manatt Health ? Denise Snyder, Duke University School of Medicine Topics include: ? What policy approaches can empower hospitals, trial sponsors, providers, and other stakeholders to manage change with their own organizations and engage with payers to foster broader coverage of trial-related activities ? How we can improve evidence generation processes within our own organizations for both healthcare systems and pharma ? How can we effectively communicate steps that Federal agencies can take to encourage stakeholder collaboration to align on incentives for improving coverage of clinical trials for patients ??? Listen here: https://lnkd.in/e5SpMnJk #CRAACO2025
-
-
In our latest white paper, Duke-Margolis researchers discuss the uses of electronic health record-sourced data, and offer best practices to advance data quality, relevance, and reliability during the accrual phase. Read more here: https://duke.is/6/4ta6